Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of Life After HIPEC in Advanced Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
NCT03188432Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2019
- Primary completion
- Jan 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Wake Forest University Health Sciences. Started Jan 2019; status: completed.
02
Drugs
carboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT03188432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188432.